Mosaic Therapeutics welcomes new CEO. Former Cimeio Therapeutics CEO Thomas Fuchs has taken the helm at Mosaic Therapeutics, ...

Obtained ex-US Regulatory Clearance for DT-818, a Potentially Best-in-Disease Treatment for Myotonic Dystrophy Type-1 (DM1) Trials of DT-216P2 in Friedreich Ataxia (FA) and DT-168 in Fuchs Endothelial ...

It: Welcome to Derry episode 4, The Great Swirling Apparatus of Our Planet's Function. See Suraj, Rana, Pat and Navi continue unraveling the chilling mystery surrounding Derrys missing children. Still ...

Here are the top medical news for the dayIndia Ranks Second Globally With 138 Million Kidney Disease Cases in 2023: Study Scientists have revealed alarming new data on the rising burden ...

Drugmaker Eli Lilly has teamed up with artificial-intelligence chip designer Nvidia to build what the companies say will be ...

This PHM 2025 session summary addresses outdated medical practices and current evidence-based approaches in pediatric care.

To build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients ...

Lilly Partners With NVIDIA To Build The Industry's Most Powerful AI Supercomputer, Supercharging Medicine Discovery And ...

"Corneal blindness is one of the leading causes of vision loss, affecting about 10 million people worldwide each year," says ...

Mosaic Therapeutics, a Cambridge-based cancer therapeutics company operating in Synergistic Precision Oncology, has made a ...